SLC4A10 and neurodevelopmental disorder: As SLC4A10 localizes to inhibitory presynapses and its disruption compromises γ-aminobutyric acid (GABA) release, we propose that alterations of the GABAergic system contribute to the pathomechanistic basis of this neurodevelopmental disorder.